Original Research
Accepted on 22 Nov 2024
Research progress of breast cancer surgery during 2010-2024: a bibliometric analysis
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1508568
- Frontiers in Oncology
- Breast Cancer
- Articles
Type at least 3 characters
1,227 articles
Articles
Perspective
Published on 22 Nov 2024
The intersection of the HER2-low subtype with endocrine resistance: the role of interconnected signaling pathways
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1461190
- 253 views
Original Research
Published on 21 Nov 2024
Mediation effects of metabolites and sex hormones on the relationship between body mass index and breast cancer: Mendelian randomization analysis and mediation analysis
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1449956
- 104 views
Case Report
Accepted on 19 Nov 2024
Triple-Negative Ectopic Breast Cancer of the Male Scrotum: A Case Report
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1473881
Review
Accepted on 19 Nov 2024
Unlocking the Epigenetic Code: New Insights into Triple-Negative Breast Cancer (TNBC)
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1499950
Original Research
Published on 19 Nov 2024
Construction of a risk prediction model for axillary lymph node metastasis in breast cancer based on gray-scale ultrasound and clinical pathological features
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1415584
- 155 views
Correction
Published on 19 Nov 2024
Corrigendum: Long-term exposure to BAY2416964 reduces proliferation, migration and recapitulates transcriptional changes induced by AHR loss in PyMT-induced mammary tumor cells
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1516633
- 108 views
Original Research
Accepted on 18 Nov 2024
RET inhibition overcomes resistance to combined CDK4/6 inhibitor and endocrine therapy in ER+ breast cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1497093
Editorial
Accepted on 18 Nov 2024
Editorial: Women in Breast Cancer Volume III 2023
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1515282
Case Report
Published on 18 Nov 2024
Case report: Triple-negative breast cancer with low tumour-infiltrating lymphocytes infiltration and good prognosis: a case of Tall Cell Carcinoma with Reversed Polarity and review of the literature
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1455893
- 145 views
Original Research
Accepted on 15 Nov 2024
Medical history of thyroid cancer does not impair prognosis in non-metastatic breast cancer patients: an analysis study based on SEER database and external cohort
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1443467
Original Research
Published on 15 Nov 2024
Breaking barriers: improving mammography screening accessibility and quality of care for breast cancer women with disabilities in Saudi Arabia
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1398061
- 367 views
Review
Published on 15 Nov 2024
An overview of invasive micropapillary carcinoma of the breast: past, present, and future
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1435421
- 152 views
Original Research
Published on 15 Nov 2024
Insulin-like growth factor-binding protein-3 is induced by tamoxifen and fulvestrant and modulates fulvestrant response in breast cancer cells
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1452981
- 274 views
Case Report
Published on 14 Nov 2024
Incidental discovery of invasive lobular carcinoma and anaplastic large cell lymphoma during sentinel lymph node biopsy: a case report
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1440126
- 179 views
Original Research
Accepted on 13 Nov 2024
The role of FDG PET assessment in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 inhibitors in the second-line setting
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2024.1454844